Phytomedicine, Год журнала: 2024, Номер 135, С. 156216 - 156216
Опубликована: Ноя. 8, 2024
Язык: Английский
Phytomedicine, Год журнала: 2024, Номер 135, С. 156216 - 156216
Опубликована: Ноя. 8, 2024
Язык: Английский
Current Issues in Molecular Biology, Год журнала: 2025, Номер 47(3), С. 160 - 160
Опубликована: Фев. 27, 2025
Metabolic-dysfunction-associated fatty liver disease (MAFLD) and alcohol-associated (ALD) represent two of the most prevalent chronic diseases globally, collectively affecting hundreds millions individuals [...]
Язык: Английский
Процитировано
0World Journal of Clinical Oncology, Год журнала: 2025, Номер 16(4)
Опубликована: Март 26, 2025
Cholangiocarcinoma (CCA) is a particularly aggressive and challenging type of cancer, known for its poor prognosis, which worsened by the complex interplay various biological environmental factors that contribute to development. Recently, researchers have increasingly focused on significant role biliary-enteric communication liver-gut axis in pathogenesis CCA, highlighting relationship has not been thoroughly explored before. This review aims summarize key concepts related investigate potential mechanisms may lead onset progression disease presents substantial treatment challenges. Important areas focus will include microbiome's profound influence, interacts with host physiology ways worsen cancer development; changes bile acid metabolism can create toxic environments favorable tumor growth; regulation inflammatory processes either promote or inhibit progression; immune system's involvement, crucial body's response cancer; interactions within metabolic pathways affect cellular behavior dynamics. By integrating recent research findings from studies, we aim explore multifaceted roles providing new insights perspectives future while identifying promising therapeutic targets could innovative strategies aimed at improving patient outcomes this disease.
Язык: Английский
Процитировано
0Clinical Nutrition ESPEN, Год журнала: 2024, Номер 63, С. 604 - 614
Опубликована: Июль 30, 2024
There is a need to identify new treatment options for depression with its comorbidities. Depression often coexists liver steatosis and the two may share pathophysiological overlap, including inflammation microbiota changes. Probiotics might represent safe option as an adjunctive therapy in patients possible steatosis. The paper presents secondary analysis of clinical trial effect probiotic supplementation on levels non-invasive markers fibrosis adult depressive disorders.
Язык: Английский
Процитировано
2Food Bioscience, Год журнала: 2024, Номер unknown, С. 105379 - 105379
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
2Phytomedicine, Год журнала: 2024, Номер 135, С. 156216 - 156216
Опубликована: Ноя. 8, 2024
Язык: Английский
Процитировано
2